Delaware
|
77-0322379
|
|
(State
or other jurisdiction of
|
(I.R.S.
Employer
|
|
incorporation
or organization)
|
Identification
No.)
|
|
PART
I
|
1
|
|||
ITEM
1. BUSINESS
|
1
|
|||
ITEM
1A. RISK FACTORS
|
9
|
|||
ITEM
1B. UNRESOLVED STAFF COMMENTS
|
14
|
|||
ITEM
2. PROPERTIES
|
14
|
|||
ITEM
3. LEGAL PROCEEDINGS
|
15
|
|||
ITEM
4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
|
15
|
|||
PART
II
|
16
|
|||
ITEM
5. MARKET FOR THE REGISTRANT’S COMMON EQUITY RELATED STOCKHOLDER MATTERS
AND ISSUER PURCHASES OF EQUITY SECURITIES
|
16
|
|||
ITEM
6. SELECTED FINANCIAL DATA
|
17
|
|||
ITEM
7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS
|
18
|
|||
ITEM
7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET
RISK
|
28
|
|||
ITEM
9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
FINANCIAL DISCLOSURE
|
28
|
|||
ITEM
9A. CONTROLS AND PROCEDURES
|
28
|
|||
ITEM
9B. OTHER INFORMATION
|
29
|
|||
PART
III
|
30
|
|||
ITEM
10. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT
|
30
|
|||
ITEM
11. EXECUTIVE COMPENSATION
|
30
|
|||
ITEM
12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
AND
RELATED STOCKHOLDER MATTERS
|
30
|
|||
ITEM
13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
|
30
|
|||
ITEM
14. PRINCIPAL ACCOUNTING FEES AND SERVICES
|
30
|
|||
PART
IV
|
31
|
|||
ITEM
15. EXHIBITS, CONSOLIDATED FINANCIAL STATEMENT SCHEDULES
|
31
|
· |
Subsequent
to the filing of the Form 10K for the year ended December 31, 2005,
the
Company identified that it had not included warrants granted to Mr.
Khashoggi, its former Chairman, in its footnote
disclosure of pro forma net loss and loss per share resulting from
applying SFAS No. 123 for 2005. Accordingly, the Company has restated
the
footnote disclosure for this information for the year ended December
2005
which resulted in an increase in its pro forma net loss and loss
per share
from $6,924,527 and $0.37 to $9,258,471 and $0.49,
respectively.
|
· |
The
Company has revised and enhanced the disclosure under Item 9A Controls
and
Procedures.
|
Global
Market Size
|
|||||||
$
|
%
|
||||||
($
in millions)
|
|||||||
Commercial
Products
|
|||||||
Plates,
Bowls
|
$
|
5,700
|
19
|
||||
Hinged-Lid
Containers
|
1,800
|
6
|
|||||
Commercial
Prototypes
|
|||||||
Wraps
|
2,000
|
7
|
|||||
Hot
Cups
|
3,300
|
11
|
|||||
Concept
Prototypes
|
|||||||
Cold
Cups
|
5,700
|
19
|
|||||
Containers,
Trays
|
4,200
|
13
|
|||||
Straws,
Cup Lids
|
3,300
|
11
|
|||||
Pizza
Boxes
|
2,000
|
7
|
|||||
Cutlery
|
2,000
|
7
|
|||||
Total
|
$
|
30,000
|
100
|
||||
· |
Develop
products which deliver comparable or greater performance, are
competitively priced and offer environmental advantages as compared
to
traditional packaging alternatives;
|
· |
Commercialize
the plate and bowl project operated at Renewable Products, Inc. (“RPI”)
and build initial brand awareness and share of
market;
|
· |
Accelerate
market penetration/sales by current licensees with shallow draw foam
analog, e.g. dinnerware line extensions and other related
items;
|
· |
Establish
and grow international business opportunities, as well as development
of
pellet technology;
|
· |
Promote
and support additional products with the greatest potential for near
term
success: a.) deep draw foam analog products, hot cups and lids, and
b.)
injection molded products.
|
· |
The
Company has inadequate segregation of critical duties within each
of its
accounting processes and a lack of sufficient monitoring controls
over
these processes to mitigate this risk. The responsibilities assigned
to
one employee include maintaining the vendor master file, processing
payables, creating and voiding checks, reconciling bank accounts,
making
bank deposits and processing
payroll.
|
· |
There
are weaknesses in the Company’s information technology controls which
makes the Company’s financial data vulnerable to error or fraud.
Specifically, there is a lack of documentation regarding the roles
and
responsibilities of the IT function, lack of security management
and
monitoring and inadequate segregation of duties involving IT
functions.
|
Quarterly
Prices
|
||||||||||||||||
First
|
Second
|
Third
|
Fourth
|
Total
Year
|
||||||||||||
2005
|
||||||||||||||||
Market
price per common share
|
||||||||||||||||
High
|
$
|
2.52
|
$
|
3.20
|
$
|
2.96
|
$
|
2.50
|
$
|
3.20
|
||||||
Low
|
1.49
|
1.65
|
1.78
|
1.74
|
1.49
|
|||||||||||
2004
|
||||||||||||||||
Market
price per common share
|
||||||||||||||||
High
|
$
|
2.52
|
$
|
2.03
|
$
|
3.75
|
$
|
2.97
|
$
|
3.75
|
||||||
Low
|
1.49
|
0.45
|
1.75
|
1.95
|
0.45
|
|||||||||||
For
the Year Ended December 31
|
||||||||||||||||
2005
|
2004
|
2003
|
2002
|
2001
|
||||||||||||
Statement
of Operations Data
|
||||||||||||||||
Revenues
|
$
|
183
|
$
|
138
|
$
|
--
|
$
|
--
|
$
|
--
|
||||||
Research
and development expenses (1)
|
201
|
1,170
|
9,547
|
26,890
|
47,148
|
|||||||||||
General
and administrative expenses
|
5,485
|
3,749
|
5,786
|
9,590
|
9,634
|
|||||||||||
Depreciation
and amortization
|
3
|
42
|
380
|
3,099
|
5,874
|
|||||||||||
Gain
on sale of property and equipment
|
(23
|
)
|
(168
|
)
|
(452
|
)
|
(441
|
)
|
--
|
|||||||
Interest
expense (income), net
|
696
|
1,068
|
1,791
|
132
|
(356
|
)
|
||||||||||
Debenture
conversion cost
|
--
|
--
|
166
|
321
|
--
|
|||||||||||
Net
loss
|
6,179
|
7,257
|
18,517
|
39,591
|
62,302
|
|||||||||||
Average
shares outstanding
|
18,503
|
15,047
|
13,267
|
11,277
|
9,353
|
|||||||||||
Balance
Sheet Data
|
||||||||||||||||
Cash
and cash equivalents
|
$
|
348
|
$
|
272
|
$
|
1,902
|
$
|
111
|
$
|
828
|
||||||
Working
capital (deficit)
|
(11,485
|
)
|
(7,289
|
)
|
(9,438
|
)
|
(8,315
|
)
|
(6,941
|
)
|
||||||
Total
assets
|
443
|
483
|
2,287
|
18,024
|
19,886
|
|||||||||||
Total
long-term obligations
|
905
|
1,475
|
4,408
|
--
|
--
|
|||||||||||
Deficit
accumulated during development stage
|
(321,669
|
)
|
(321,607
|
)
|
(314,351
|
)
|
(295,834
|
)
|
(256,243
|
)
|
||||||
Stockholders’
equity (deficit)
|
(12,352
|
)
|
(8,755
|
)
|
(12,269
|
)
|
(3,473
|
)
|
11,536
|
|||||||
Shares
outstanding
|
18,981
|
18,235
|
14,129
|
12,055
|
9,860
|
|||||||||||
Per
Common Share
|
||||||||||||||||
Basic
and diluted loss per share
|
$
|
0.33
|
$
|
0.48
|
$
|
1.40
|
$
|
3.51
|
$
|
6.66
|
||||||
(1) |
During
1998, the Company entered into a 5 year purchase commitment with
a
supplier whereby the supplier would be entitled to a minimum fee
of $3.5
million. The fee would be waived if supplier received an aggregate
of $70
million in orders over the 5 year period from 1998 through 2003.
As of
December 31, 2002, it was apparent that the purchase commitment would
not
be met and the Company recorded the liability for the $3.5 million
fee and
as a charge to Other Research and Development Expense. However, during
the
4th
quarter of 2003, the Company was able to negotiate a reduction of
the $3.5
million fee to approximately $1.7 million. Accordingly, the difference
of
$1.8 million was recorded as a credit to Other Research and Development
Expense in 2003. See “Commitments” in the Notes to Consolidated Financial
Statements.
|
· |
Related
party license fee and research and development expenses decreased
$0.8
million to $0 from $.8 million for the year ended December 31, 2005
compared to the year ended December 31, 2004, respectively. Prior to
2005, related party license fee and research and development expenses
were
comprised a $0.1 million minimum monthly licensing fee for the use
of the
EarthShell technology and for technical services, both of which were
payable to EKI, a principal stockholder of the Company, or Biotec,
a
wholly-owned subsidiary of EKI. The minimum monthly licensing fee
to
Biotec was terminated in 2004.
|
· |
Other
research and development expenses are comprised of personnel costs,
travel
and direct overhead for development and demonstration production,
as well
as impairment charges on manufacturing property and equipment constructed
for demonstration production purposes. Other research and development
expenses decreased $0.2 million to $0.2 million from $0.4 million
for the
year ended December 31, 2005 compared to the year ended
December 31, 2004, respectively. The reduction is due to the Company
focusing its efforts on the licensing business model whereby licensees
and
future licensees will install and run the equipment to produce EarthShell
Packaging in their facilities.
|
· |
Related
party interest expense decreased $0.3 million to $0.1 million from
$0.4
million for the years ended December 31, 2005 and 2004, respectively.
Related party interest expense includes interest accrued on outstanding
loans made to the Company by EKI under the Loan Agreement (see
“Business - Relationship with EKI”), accretion of the discount related to
the warrants issued to EKI in conjunction with the March 2003 financing
transactions, plus accrued interest payable on amounts owed to EKI
for
monthly licensing fees that were accrued rather than being paid in
accordance with the terms of the subordination agreements entered
into in
connection with the 2006 Debentures (see “Business - Relationship
with EKI”). During the third quarter of 2004, agreements were negotiated
with EKI to convert the EKI Simple Interest Loans, and accrued but
unpaid
interest, into common stock of the Company and to restructure the
unpaid
licensing fees under the Biotec License Agreement (see “Item 1 - Business
Relationship with EKI”).
|
· |
Other
interest expense decreased $0.1 million to $0.6 million from $0.7
million
for the year ended December 31, 2005 compared to the year ended
December 31, 2004, respectively. Other interest expense for 2005 is
primarily comprised of accretion of the discount and interest accrued
on
the CCP Notes. Other interest expense for 2004 was primarily comprised
of
accretion of discount on the 2006
Debentures.
|
· |
Related
party license fee and research and development expenses are comprised
of
the $.1 million minimum monthly licensing fee for the use of the
EarthShell technology and for technical services, both of which were
payable to EKI, a stockholder of the Company, or Biotec, a wholly-owned
subsidiary of EKI. Related party license fee and research and development
expenses decreased $0.5 million to $0.8 million from $1.3 million
for the
year ended December 31, 2004 compared to the year ended
December 31, 2003, respectively. The decrease was primarily due to a
decrease in the license fee as a result of an agreement with Biotec
to
eliminate the $0.1 million per month minimum licensing
fee.
|
· |
Other
research and development expenses are comprised of personnel costs,
travel
and direct overhead for development and demonstration production,
as well
as impairment charges on manufacturing property and equipment constructed
for demonstration production purposes. Other research and development
expenses decreased $7.8 million to $0.4 million from $8.2 million
for the
year ended December 31, 2004 compared to the year ended
December 31, 2003, respectively. The reduction was due to the
non-recurrence of the following 2003 activities: the winding down
of
on-going demonstration manufacturing in Goleta, California in the
first
quarter of 2003, the start-up in mid-May of a new manufacturing line
for
plates and bowls built and financed by Detroit Tool and Engineering
Company (DTE) at their Lebanon, Missouri facility, expenses
incurred to vacate the Company’s demonstration manufacturing facility in
Goleta at the expiration of the lease on May 31, 2003, costs incurred
in
connection with testing of the Goettingen, Germany manufacturing
equipment
during the third quarter, the write down of the Goettingen manufacturing
equipment to $1 as of December 31, 2003 due to the uncertainty of the
proceeds to be realized upon sale of the equipment, and the losses
of the
Company’s joint venture. In early August 2003, the Company discontinued
its day-to-day support of manufacturing activities at DTE. In keeping
with
its business model, in 2004 the Company primarily focused on the
licensing
of its foam analog material and other technologies to new licensees,
and
these licensees and future licensees will install and run equipment
to
produce EarthShell Packaging in their own
facilities.
|
· |
Related
party interest expense was $0.4 million for both the year ended
December 31, 2004 and the year ended December 31, 2003. Related
party interest expense includes interest accrued on outstanding loans
made
to the Company by EKI under the Simple Interest Loan Agreement (see
“Related Party Transactions”), accretion of the discount related to the
warrants issued to EKI in conjunction with the March 2003 financing
transactions, plus accrued interest payable on amounts owed to EKI
for
monthly licensing fees that were accrued rather than being paid in
accordance with the terms of the subordination agreements entered
into in
connection with the 2006 Debentures (see “Business - Relationship
with EKI”). During the third quarter of 2004, agreements were negotiated
with EKI to convert the EKI Simple Interest Loans, and accrued but
unpaid
interest, into common stock of the Company and to restructure the
unpaid
licensing fees under the Biotec License Agreement (see “Item 1 Business
Relationship with EKI”).
|
· |
Other
interest expense decreased $0.7 million to $0.7 million from $1.4
million
for the year ended December 31, 2004 compared to the year ended
December 31, 2003, respectively. Other interest expense for 2004 is
primarily comprised of accretion of the discount and interest accrued
on
the 2006 Debentures. Other interest expense for 2003 was primarily
comprised of accretion of discount on the 2006 Debentures and a beneficial
conversion charge in the amount of $0.4 million due to a change in
the
2007 Debentures conversion price. In addition, Other interest expense
for
2003 also included accretion of the discount on the 2007 Debentures
and
accrued interest payable on the 2006 and 2007
Debentures.
|
Payments
due by period
(in
thousands)
|
Less
than
|
1-3
|
||||||||
Contractual
Obligations
|
Total
|
1
year
|
Years
|
|||||||
Note
payable to related party (including interest)
|
$
|
1,225
|
$
|
75
|
$
|
1,150
|
||||
Notes
payable
|
2,600
|
2,600
|
||||||||
Convertible
debenture
|
4,500
|
—
|
4,500
|
|||||||
Other
long-term liability
|
427
|
307
|
120
|
|||||||
Totals
|
$
|
8,507
|
$
|
2,982
|
$
|
5,770
|
· |
The
Company has inadequate segregation of critical duties within each
of its
accounting processes and a lack of sufficient monitoring controls
over
these processes to mitigate this risk. The responsibilities assigned
to
one employee include maintaining the vendor master file, processing
payables, creating and voiding checks, reconciling bank accounts,
making
bank deposits and processing
payroll.
|
· |
The
departure of the Company's Controller in November 2004 resulted in
the
accounting and reporting functions being centralized under the Chief
Financial Officer, with no additional personnel in the Company having
an
adequate knowledge of accounting principles and practices. As a result,
certain transactions had not been recorded in a timely manner and
several
adjustments to the financial statements that were considered material
to
the financial position at December 31, 2005 and 2004 and results
of
operations for the years then ended were
recorded.
|
· |
There
are weaknesses in the Company's information technology ("IT") controls
which makes the Company's financial data vulnerable to error or fraud.
Specifically, there is a lack of documentation regarding the roles
and
responsibilities of the IT function, lack of security management
and
monitoring and inadequate segregation of duties involving IT
functions.
|
· |
Management
interviewed multiple qualified candidates to perform the Controller
responsibilities, and as of October 31, 2005 hired a new controller
who is
a CPA, with 15 years experience in public and private accounting.
The new
Controller is in the process of developing revised accounting systems
and
procedures that will strengthen the Company's controls over financial
reporting. Subsequent to December 31, 2005, the Company hired an
additional accounting employee on March 30, 2006 to help segregate
critical accounting functions to improve internal control over financial
reporting.
|
· |
Management
employs an outside firm, to monitor and maintain the Company's information
systems. This group was been directed to develop and implement
Company-wide information management control procedures in response
to the
control weaknesses noted by the Company's auditors and in consultation
with the Company's internal auditors. A first draft was completed
in July
2005. In connection with the recent move of its corporate offices
to
Maryland, a new group was retained to perform a similar function.
It is
expected that a final information technology controls policy and
procedures document will be finalized and implemented by year-end,
2007.
|
1.
Consolidated Financial Statements:
|
||||
Report
of Independent Registered Public Accounting Firm
|
F-2
|
|||
Consolidated
Balance Sheets as of December 31, 2005, and 2004
|
F-3
|
|||
Consolidated
Statements of Operations for the years ended
|
||||
December 31,
2005, 2004 and 2003
|
F-4
|
|||
Consolidated
Statements of Stockholders’ Equity (Deficit) for
the
|
||||
years
ended December 31, 2005, 2004 and 2003
|
F-5
|
|||
Consolidated
Statements of Cash Flows for the years ended
|
||||
December 31,
2005, 2004 and 2003
|
F-6
|
|||
Notes
to the Consolidated Financial Statements
|
F-9
|
3.1
|
Amended
and Restated Certificate of Incorporation of the
Company.(1)
|
|
3.2
|
Amended
and Restated Bylaws of the Company.(1)
|
|
3.3
|
Certificate
of Designation, Preferences Relative, Participating, Optional and
Other
Special Rights of the Company’s Series A Cumulative Senior Convertible
Preferred Stock.(1)
|
|
4.1
|
Specimen
certificate of Common Stock.(1)
|
|
4.2
|
Form
of Warrant to purchase Common Stock dated August 12,
2002.(9)
|
|
4.3
|
Form
of Note under Loan Agreement dated as of September 9, 2002 between
the
Company and E. Khashoggi Industries, LLC.(11)
|
|
4.4
|
Form
of Secured Convertible Debenture due March 5, 2006.(13)
|
|
4.5
|
Intellectual
Property Security Agreement dated as of March 5, 2003 among the Company,
E. Khashoggi Industries, LLC and the investors signatory
thereto.(13)
|
|
4.6
|
Waiver
and Amendment to Debentures and Warrants dated as of March 5, 2003
among
the Company and the purchasers identified on the signature pages
thereto.(13)
|
|
4.7
|
Exchange
Agreement dated as of March 5, 2003 between the Company and the
institutional investor signatory thereto.(13)
|
|
4.8
|
Investor
Rights Agreement dated as of December 9, 2005, by and among EarthShell
Corporation and the parties signatory thereto. (19)
|
|
4.9
|
Form
of EarthShell Corporation Common Stock Warrant dated February 10,
2006
(19)
|
|
10.1
|
Amended
and Restated License Agreement dated February 28, 1995 by and between
the
Company and E. Khashoggi Industries(“EKI”).(1)
|
|
10.2
|
Registration
Rights Agreement dated as of February 28, 1995 by and between the
Company
and EKI, as amended.(1)
|
|
10.3
|
EarthShell
Container Corporation 1994 Stock Option Plan.(1)
|
|
10.4
|
EarthShell
Container Corporation 1995 Stock Incentive Plan.(1)
|
|
10.5
|
Form
of Stock Option Agreement under the EarthShell Container Corporation
1994
Stock Option Plan.(1)
|
|
10.6
|
Form
of Stock Option Agreement under the EarthShell Container Corporation
1995
Stock Incentive Plan.(1)
|
|
10.7
|
Warrant
to Purchase Stock issued July 2, 1996 by the Company to Imperial
Bank.(1)
|
|
10.8
|
Amended
and Restated Technical Services and Sublease Agreement dated October
1,
1997 by and between the Company and EKI.(1)
|
|
10.9
|
Amended
and Restated Agreement for Allocation of Patent Costs dated October
1,
1997 by and between the Company and EKI.(1)
|
|
10.10
|
Warrant
to Purchase Stock issued October 6, 1997 by the Company to Imperial
Bank.(1)
|
|
10.11
|
Warrant
to Purchase Stock dated December 31, 1997 by the Company to Imperial
Bank.(1)
|
|
10.12
|
Letter
Agreement re Haas/BIOPAC Technology dated February 17, 1998 by and
between
the Company and EKI.(1)
|
|
10.13
|
Second
Amendment to 1995 Stock Incentive Plan of the
Company.(1)
|
|
10.14
|
Amendment
No. 2 to Registration Rights Agreement dated as of September 16,
1993.(1)
|
|
10.15
|
Amendment
No. 2 to Registration Rights Agreement dated February 28,
1995.(1)
|
|
10.16
|
Employment
Agreement dated April 15, 1998 by and between the Company and Vincent
J.
Truant.(3)
|
|
10.17
|
First
Amendment dated June 2, 1998 to the Amended and Restated License
Agreement
by and between the Company and E. Khashoggi
Industries(“EKI”).(4)
|
|
10.18
|
First
Amendment to 1995 Stock Incentive Plan of the
Company.(5)
|
|
10.19
|
Third
Amendment to 1995 Stock Incentive Plan of the
Company.(6)
|
|
10.20
|
Fourth
Amendment to 1995 Stock Incentive Plan of the
Company.(6)
|
|
10.21
|
Lease
Agreement dated August 23, 2000 by and between the Company and Heaver
Properties, LLC.(7)
|
|
10.22
|
Settlement
Agreement with Novamont dated August 3, 2001.(8)
|
|
10.23
|
Amendment
to Common Stock Purchase Agreement dated March 28,
2001.(8)
|
|
10.24
|
Securities
Purchase Agreement dated as of August 12, 2002 between the Company
and the
investors signatory thereto.(9)
|
|
10.25
|
Amendment
#1 to Employment Agreement dated as of May 15, 2002 by and between
the
Company and Vince Truant.(10)
|
|
10.26
|
Loan
Agreement dated as of September 9, 2002 between the Company and E.
Khashoggi Industries, LLC.(11)
|
|
10.27
|
Second
Amendment dated 29 July, 2002 to Amended and Restated License Agreement
between E. Khashoggi Industries, LLC and the
Company.(12)
|
|
10.28
|
License
and Information Transfer Agreement dated 29 July, 2002 between the
Biotec
Group and the Company.(12)
|
|
10.29
|
Loan
and Securities Purchase Agreement dated as of March 5, 2003 between
the
Company and the investors signatory thereto.(13)
|
|
10.30
|
Sublicense
Agreement dated February 20, 2004 by and between the Company and
Hood
Packaging Corporation. (15)
|
|
10.31
|
Operating
and Sublicense Agreement dated October 3, 2002 by and between the
Company
and Sweetheart Cup Company, Inc. (15)
|
|
10.32
|
First
Amendment to Operating and Sublicense Agreement dated July 2003 by
and
between the Company and Sweetheart Cup Company,
Inc. (15)
|
|
10.34
|
Lease
Agreement dated July 2003 between the Company and Sweetheart Cup
Company,
Inc. (15)
|
|
10.35
|
First
Amendment to Lease Agreement dated December 16, 2003 between the
Company and Sweetheart Cup Company, Inc. (15)
|
|
10.37
|
Sublicense
Agreement dated November 11, 2004 by and between the Company and
EarthShell Hidalgo S.A. de C.V.. (18)
|
|
10.38
|
Standby
Equity Distribution Agreement dated as of March 23, 2005 between
the
Company and Cornell Capital Partners, LP. (16)
|
|
10.39
|
Registration
Rights Agreement dated as of March 23, 2005 between the Company and
Cornell Capital Partners, LP. (16)
|
|
10.40
|
Placement
Agent Agreement dated as of March 23, 2005 by and among the Company,
Cornell Capital Partners, LP and Sloan Securities
Corporation. (16)
|
|
10.41
|
Security
Agreement dated as of March 23, 2005 between the Company and Cornell
Capital Partners, LP. (16)
|
|
10.42
|
Promissory
Note dated as of March 23, 2005 issued to Cornell Capital Partners,
LP. (16)
|
|
10.43
|
Meridian
Business Solutions Sublicense Agreement dated May 13,
2004. (17)
|
|
10.44
|
Amended
and Restated Debenture Purchase Agreement by and among the Company,
EKI
and SF Capital Partners, Ltd. dated September 30,
2004. (17)
|
|
10.45
|
Amended
and Restated Debenture Purchase Agreement by and among the Company,
EKI
and Omicron Master Trust dated September 29,
2004. (17)
|
|
10.46
|
Amended
and Restated Debenture Purchase Agreement by and among the Company,
EKI
and Islandia, Ltd. dated September 29, 2004. (17)
|
|
10.47
|
Amended
and Restated Debenture Purchase Agreement by and among the Company,
EKI
and Midsummer Investment, Ltd. dated September 29,
2004. (17)
|
|
10.48
|
Conversion
Agreement by and among the Company, EKI and RHP Master Fund, Ltd.
dated
July 20, 2004. (17)
|
|
10.49
|
Amended
and Restated Debenture Purchase Agreement by and among the Company,
EKI
and Straus-GEPT L.P. dated September 29,
2004. (17)
|
|
10.50
|
Amended
and Restated Debenture Purchase Agreement by and among the Company,
EKI
and Straus Partners L.P. dated September 29,
2004. (17)
|
|
10.51
|
Amended
and Restated Debenture Purchase Agreement by and among the Company
and EKI
dated September 30, 2004. (17)
|
|
10.52
|
Agreement
with EKI dated July 16, 2004 to convert debt to
equity. (17)
|
|
10.53
|
Agreement
dated September 1, 2004 for conversion of Biotec indebtedness.
(17)
|
|
10.54
|
Stock
Purchase Agreement between the Company and Meridian Business Solutions,
LLC dated August 5, 2004. (17)
|
|
10.55
|
Warrant,
dated May 26, 2005, issued by the Company to Cornell Capital Partners,
LP
(20)
|
|
10.56
|
Letter
Agreement dated as of December 9, 2005, by and between EarthShell
Corporation and EarthShell Asia, Limited. (19)
|
|
10.57
|
Securities
Purchase Agreement dated as of December 30, 2005, by and between
EarthShell Corporation and Cornell Capital Partners, LP
(21)
|
|
10.58
|
Investor
Registration Rights Agreement dated as of December 30, 2005 by and
between
EarthShell Corporation and Cornell Capital Partners, LP
(21)
|
|
10.59
|
Secured
Convertible Debenture dated as of December 30, 2005, issued to Cornell
Capital Partners, LP (21)
|
|
10.60
|
Amended
and Restated Security Agreement dated as of December 30, 2005, by
and
between EarthShell Corporation and Cornell Capital Partners, LP
(21)
|
|
10.61
|
Warrant
dated as of December 30, 2005 issued to Cornell Capital Partners,
LP
(21)
|
|
10.62
|
Pledge
and Escrow Agreement dated as of December 30, 2005 among Corporation,
Cornell Capital Partners, LP and David Gonzalez, Esq.
(21)
|
|
10.63
|
Escrow
Agreement dated December 30, 2005 among EarthShell Corporation, Cornell
Capital Partners, LP and David Gonzalez, Esq. (21)
|
|
10.64
|
Irrevocable
Transfer Agent Instructions dated as of December 30, 2005, by and
between
EarthShell Corporation and Cornell Capital Partners, LP
(21)
|
|
10.65
|
Insider
Pledge and Escrow Agreement dated December 30, 2005 by and among
EarthShell Corporation, Cornell Capital Partners, LP, David Gonzalez,
Esq.
and Benton Wilcoxon (21)
|
|
10.66
|
Termination
Agreement dated December 30, 2005 by and between EarthShell Corporation,
Cornell Capital Partners, LP and Sloan Securities Corporation
(21)
|
|
10.77
|
Irrevocable
Transfer Agent Instructions dated as of December 30, 2005 by and
between
EarthShell Corporation, Cornell Capital Partners, LP and David Gonzalez,
Esq. regarding the Convertible Debentures (21)
|
|
10.78
|
Form
of Lockup Agreement (21)
|
|
14.1
|
EarthShell
Corporation Code of Ethics for Directors, Officers and Employees
(15)
|
|
16.1
|
Letter
from Deloitte & Touche LLP to the Securities and Exchange Commission
dated July 9, 2003, regarding change in certifying
accountant. (14)
|
|
31.1
|
Certification
of the CEO pursuant to Rules 13a-14 and 15d-14 under the Exchange
Act, as
adopted pursuant to Section 302 of the Sarbanes-Oxley Act of
2002.
|
|
31.2
|
Certification
of the CFO pursuant to Rules 13a-14 and 15d-14 under the Exchange
Act, as
adopted pursuant to Section 302 of the Sarbanes-Oxley Act of
2002.
|
|
32.1
|
Certification
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section
906 of
the Sarbanes-Oxley Act of 2002.
|
(1)
|
Previously
filed, as an exhibit to the Company’s Registration Statement on Form S-1
and amendments thereto, File no. 333-13287, and incorporated herein
by
reference.
|
(2)
|
Previously
filed as an exhibit to the Company’s quarterly report on Form 10-Q, for
the quarter ended March 31, 1998, and incorporated herein by
reference.
|
(3)
|
Previously
filed as an exhibit to the Company’s quarterly report on Form 10-Q, for
the quarter ended June 30, 1998, and incorporated herein by
reference.
|
(4)
|
Previously
filed as an exhibit to the Company’s quarterly report on Form 10-Q, for
the quarter ended September 30, 1998, and incorporated herein by
reference.
|
(5)
|
Previously
filed as an exhibit to the Company’s annual report on Form 10-K, for the
fiscal year ended December 31, 1998, and incorporated herein by
reference.
|
(6)
|
Previously
filed as part of the Company’s definitive proxy statement on Schedule 14A,
file no. 000-23567, for its 1999 annual meeting of stockholders,
and
incorporated herein by reference.
|
(7)
|
Previously
filed as an exhibit to the Company’s annual report on Form 10-K, for the
fiscal year ended December 31, 2000, and incorporated herein by
reference.
|
(8)
|
Previously
filed as an exhibit to the Company’s quarterly report on Form 10-Q, for
the quarter ended June 30, 2001, and incorporated
herein.
|
(9)
|
Previously
filed as an exhibit to the Company’s current report on Form 8-K dated
August 12, 2002, and incorporated herein by
reference.
|
(10)
|
Previously
filed as an exhibit to the Company’s quarterly report on Form 10-Q for the
quarter ended June 30, 2002, and incorporated herein by
reference.
|
(11)
|
Previously
filed as an exhibit to the Company’s current report on Form 8-K dated
September 17, 2002, and incorporated herein by
reference.
|
(12)
|
Previously
filed as an exhibit to the Company’s quarterly report on Form 10-Q for the
quarter ended September 30, 2002, and incorporated herein by
reference.
|
(13)
|
Previously
filed as an exhibit to the Company’s current report on Form 8-K dated
March 5, 2003, and incorporated herein by
reference.
|
(14)
|
Previously
filed as an exhibit to the Company’s current report on Form 8-K dated July
11, 2003, and incorporated herein by
reference.
|
(15)
|
Previously
filed as an exhibit to the Company’s annual report on Form 10-K, for the
fiscal year ended December 31, 2003, and incorporated herein by
reference.
|
(16)
|
Previously
filed as an exhibit to the Company’s current report on Form 8-K dated
March 29, 2005, and incorporated herein by
reference.
|
(17)
|
Previously
filed as part of the Company’s quarterly report on Form 10-Q for the
quarter ended September 30, 2004, and incorporated herein by
reference.
|
(18) |
Previously
filed as an exhibit to the Company’s annual report on Form 10-K for the
fiscal year ended December 31, 2004, and incorporated herein by
reference.
|
(19) |
Previously
filed as an exhibit to the Company’s current report on Form 8-K dated
February 10, 2006
|
(20) |
Previously
filed as an exhibit to the Company’s current report on Form 8-K dated May
26, 2005
|
(21) |
Previously
filed as an exhibit to the Company’s current report on Form 8-K dated
December 30, 2005
|
EARTHSHELL
CORPORATION
|
||
|
|
|
By: | /s/ VINCENT J. TRUANT | |
Vincent
J. Truant
|
||
Chairman
of the Board and
Chief
Executive Officer
|
Signature
|
Title
|
Date
|
||
/s/
VINCENT J. TRUANT
|
Chairman
of the Board and
|
November
1, 2006
|
||
Vincent
J. Truant
|
Chief
Executive Officer
|
|||
/s/
D. SCOTT HOUSTON
|
Chief
Financial Officer and Secretary
|
November
1, 2006
|
||
D.
Scott Houston
|
|
|||
/s/
PAUL
B. SUSIE
|
Principal
Accounting Officer
|
November
1, 2006
|
||
Paul
B. Susie
|
||||
/s/
HAMLIN JENNINGS
|
Director
|
November
1, 2006
|
||
Hamlin
Jennings
|
||||
/s/
WALKER RAST
|
Director
|
November
1, 2006
|
||
Walker
Rast
|
||||
/s/
MICHAEL GORDON
|
Director
|
November
1, 2006
|
||
Michael
Gordon
|
Index
to Consolidated Financial Statements and Schedules
|
F-i
|
|||
Report
of Independent Registered Public Accounting Firm
|
F-1
|
|||
Consolidated
Balance Sheets as of December 31, 2005 and 2004
|
F-2
|
|||
Consolidated
Statements of Operations for the years ended December 31, 2005, 2004,
and 2003
|
F-3
|
|||
Consolidated
Statements of Stockholders’ Equity (Deficit) for the years ended
December 31, 2005, 2004, and 2003
|
F-4
|
|||
Consolidated
Statements of Cash Flows for the years ended December 31, 2005, 2004,
and 2003
|
F-5
|
|||
Notes
to Consolidated Financial Statements
|
F-8
|
December 31,
|
|||||||
2005
|
2004
|
||||||
ASSETS
|
|||||||
CURRENT
ASSETS
|
|||||||
Cash
and cash equivalents
|
$
|
347,812
|
$
|
272,371
|
|||
Prepaid
expenses and other current assets
|
83,473
|
201,467
|
|||||
Total
current assets
|
431,285
|
473,838
|
|||||
PROPERTY
AND EQUIPMENT, NET
|
11,991
|
9,037
|
|||||
EQUIPMENT
HELD FOR SALE
|
1
|
1
|
|||||
TOTAL
ASSETS
|
$
|
443,277
|
$
|
482,876
|
|||
LIABILITIES
AND STOCKHOLDERS’ DEFICIT
|
|||||||
CURRENT
LIABILITIES
|
|||||||
Accounts
payable and accrued expenses
|
$
|
5,908,670
|
$
|
3,899,526
|
|||
Current
portion of settlements
|
300,786
|
313,743
|
|||||
Current
portion of deferred revenues
|
100,000
|
300,000
|
|||||
Payable
to related party, current
|
850,000
|
875,000
|
|||||
Debenture
settlement
|
2,375,000
|
2,375,000
|
|||||
Note
Payable, net of discount of $168,901
|
2,355,296
|
—
|
|||||
Total
current liabilities
|
11,889,752
|
7,763,269
|
|||||
DEFERRED
REVENUES, LESS CURRENT PORTION
|
787,500
|
1,062,500
|
|||||
OTHER
LONG-TERM LIABILITIES
|
117,914
|
412,192
|
|||||
Total
liabilities
|
12,795,166
|
9,237,961
|
|||||
COMMITMENTS
AND CONTINGENCIES
|
|||||||
STOCKHOLDERS’
DEFICIT
|
|||||||
Preferred
Stock, $.01 par value, 10,000,000 shares authorized; 9,170,000
Series A
shares designated; no shares issued and outstanding as of December
31,
2005 and 2004
|
—
|
—
|
|||||
Common
stock, $.01 par value, 40,000,000 shares authorized; 18,981,167
and
18,234,615 shares issued and outstanding as of December 31, 2005 and
2004, respectively
|
189,812
|
182,346
|
|||||
Additional
paid-in common capital
|
315,306,825
|
313,196,905
|
|||||
Accumulated
deficit
|
(327,786,868
|
)
|
(321,607,782
|
)
|
|||
Less
note receivable for stock
|
—
|
(500,000
|
)
|
||||
Accumulated
other comprehensive loss
|
(61,658
|
)
|
(26,554
|
)
|
|||
Total
stockholders’ deficit
|
(12,351,889
|
)
|
(8,755,085
|
)
|
|||
TOTAL
LIABILITES AND STOCKHOLDERS’ DEFICIT
|
$
|
443,277
|
$
|
482,876
|
Year
Ended December 31,
|
||||||||||
2005
|
2004
|
2003
|
||||||||
Revenues
|
$
|
183,333
|
$
|
137,500
|
$
|
—
|
||||
Operating
Expenses
|
||||||||||
Related
party license fee and research and development expenses
|
—
|
800,000
|
1,312,374
|
|||||||
Other
research and development expenses
|
200,817
|
370,163
|
8,234,416
|
|||||||
General
and administrative expenses
|
5,485,358
|
3,753,902
|
5,790,473
|
|||||||
Related
party general and
administrative (reimbursements)
|
—
|
(4,875
|
)
|
(4,074
|
)
|
|||||
Depreciation
and amortization
|
2,939
|
42,236
|
379,949
|
|||||||
Gain
on sales of property and equipment
|
(23,477
|
)
|
(168,458
|
)
|
(451,940
|
)
|
||||
Total
operating expenses
|
5,665,637
|
4,792,968
|
15,261,198
|
|||||||
Operating
Loss
|
5,482,304
|
4,655,468
|
15,261,198
|
|||||||
Other (Income) Expenses
|
||||||||||
Interest
income
|
(5,022
|
)
|
(4,606
|
)
|
(95,176
|
)
|
||||
Related
party interest expense
|
101,314
|
410,965
|
445,628
|
|||||||
Other
interest expense
|
599,690
|
661,721
|
1,440,118
|
|||||||
Premium
due to debenture default
|
—
|
1,672,426
|
—
|
|||||||
Other
income
|
—
|
—
|
(399,701
|
)
|
||||||
(Gain) Loss
on extinguishment of debentures
|
—
|
(139,673
|
)
|
1,697,380
|
||||||
Debenture
conversion costs
|
—
|
—
|
166,494
|
|||||||
Loss
Before Income Taxes
|
6,178,286
|
7,256,301
|
18,515,941
|
|||||||
Income
Taxes
|
800
|
800
|
800
|
|||||||
Net
Loss
|
$
|
6,179,086
|
$
|
7,257,101
|
$
|
18,516,741
|
||||
Basic
and Diluted Loss Per Common Share
|
$
|
0.33
|
$
|
0.48
|
$
|
1.40
|
||||
Weighted
Average Number of Common Shares Outstanding
|
18,503,207
|
15,046,726
|
13,266,668
|
|
|
Common
Stock
|
|
Additional
Paid-In Common
|
|
Accumulated
|
|
Stock
Purchase
|
|
Accumulated
Other Comprehensive
|
||||||||||||
Shares
|
Amount
|
Capital
|
Deficit
|
Receivable
|
Loss
|
Totals
|
||||||||||||||||
BALANCE,
DECEMBER 31, 2002
|
12,054,637
|
120,546
|
292,257,340
|
(295,833,940
|
)
|
—
|
(16,632
|
)
|
(3,472,686
|
)
|
||||||||||||
Issuance
of common stock
|
137,264
|
1,373
|
811,267
|
—
|
—
|
—
|
812,640
|
|||||||||||||||
Common
stock and common stock warrants issued in connection with issuance
of
convertible debentures
|
624,747
|
6,248
|
2,921,594
|
—
|
—
|
—
|
2,927,842
|
|||||||||||||||
Conversion
of convertible debentures to common stock
|
1,312,318
|
13,123
|
7,536,877
|
—
|
—
|
—
|
7,550,000
|
|||||||||||||||
Debenture
conversion costs
|
—
|
—
|
(1,493,332
|
)
|
—
|
—
|
—
|
(1,493,332
|
)
|
|||||||||||||
Net
loss
|
—
|
—
|
—
|
(18,516,741
|
)
|
—
|
—
|
(18,516,741
|
)
|
|||||||||||||
Foreign
currency translation adjustment
|
—
|
—
|
—
|
—
|
—
|
(76,498
|
)
|
(76,498
|
)
|
|||||||||||||
Comprehensive
loss
|
—
|
—
|
—
|
—
|
—
|
—
|
(18,593,239
|
)
|
||||||||||||||
BALANCE,
DECEMBER 31, 2003
|
14,128,966
|
141,290
|
302,033,746
|
(314,350,681
|
)
|
—
|
(93,130
|
)
|
(12,268,775
|
)
|
||||||||||||
Issuance
of common stock
|
2,443,272
|
24,432
|
7,181,970
|
—
|
(500,000
|
)
|
—
|
6,706,402
|
||||||||||||||
Conversion
of convertible debentures to common stock
|
1,662,377
|
16,624
|
4,970,508
|
—
|
—
|
—
|
4,987,132
|
|||||||||||||||
Debenture
conversion costs
|
—
|
—
|
(989,319
|
)
|
—
|
—
|
—
|
(989,319
|
)
|
|||||||||||||
Net
loss
|
—
|
—
|
—
|
(7,257,101
|
)
|
—
|
—
|
(7,257,101
|
)
|
|||||||||||||
Foreign
currency translation adjustment
|
—
|
—
|
—
|
—
|
—
|
66,576
|
66,576
|
|||||||||||||||
Comprehensive
loss
|
—
|
—
|
—
|
—
|
—
|
—
|
(7,190,525
|
)
|
||||||||||||||
BALANCE,
DECEMBER 31, 2004
|
18,234,615
|
$
|
182,346
|
$
|
313,196,905
|
$
|
(321,607,782
|
)
|
$
|
(500,000
|
)
|
$
|
(26,554
|
)
|
$
|
(8,755,085
|
)
|
|||||
Issuance
of common stock
|
266,667
|
2,667
|
797,333
|
—
|
500,000
|
—
|
1,300,000
|
|||||||||||||||
Conversion
of related party note to common stock
|
323,435
|
3,234
|
934,670
|
—
|
—
|
—
|
937,904
|
|||||||||||||||
Common
stock and common stock warrants issued in connection with issuance
of
convertible debentures
|
156,450
|
1,565
|
377,917
|
—
|
—
|
—
|
379,482
|
|||||||||||||||
Net
loss
|
—
|
—
|
—
|
(6,179,086
|
)
|
—
|
—
|
(6,179,086
|
)
|
|||||||||||||
Foreign
currency translation adjustment
|
—
|
—
|
—
|
—
|
—
|
(35,104
|
)
|
(35,104
|
)
|
|||||||||||||
Comprehensive
loss
|
—
|
—
|
—
|
—
|
—
|
—
|
(6,214,190
|
)
|
||||||||||||||
BALANCE,
DECEMBER 31, 2005
|
18,981,167
|
$
|
189,812
|
$
|
315,306,825
|
$
|
(327,786,868
|
)
|
—
|
$
|
(61,658
|
)
|
$
|
(12,351,889
|
)
|
Year
Ended December 31,
|
||||||||||
2005
|
2004
|
2003
|
||||||||
CASH
FLOWS FROM OPERATING ACTIVITIES
|
||||||||||
Net
loss
|
$
|
(6,179,086
|
)
|
$
|
(7,257,101
|
)
|
$
|
(18,516,741
|
)
|
|
Adjustments
to reconcile net loss to net cash used in operating
activities
|
||||||||||
Bad
debt expense
|
183,333
|
—
|
—
|
|||||||
Depreciation
and amortization
|
2,939
|
42,236
|
379,949
|
|||||||
Amortization
and accretion of debenture issue costs
|
633,490
|
592,316
|
955,574
|
|||||||
Compensation
related to restricted stock issuance to directors
|
150,934
|
—
|
—
|
|||||||
Interest
paid in common stock
|
100,758
|
—
|
—
|
|||||||
Premium
due to debenture default
|
—
|
1,672,426
|
—
|
|||||||
Debenture
issuance and conversion costs
|
—
|
—
|
166,494
|
|||||||
Gain
on change in fair value of warrant obligation
|
—
|
—
|
(399,701
|
)
|
||||||
(Gain) Loss
on extinguishment of debentures
|
—
|
(139,673
|
)
|
1,697,380
|
||||||
Beneficial
conversion value due to change in debentures conversion
price
|
—
|
—
|
360,000
|
|||||||
(Gain) Loss
on sale, disposal or impairment of property and equipment
|
(23,476
|
)
|
(168,458
|
)
|
3,548,059
|
|||||
Equity
in the losses of joint venture
|
—
|
—
|
392,116
|
|||||||
Accrued
purchase commitment
|
—
|
—
|
(1,855,000
|
)
|
||||||
Other
non-cash expense items
|
(223,962
|
)
|
180,171
|
50,198
|
||||||
Changes
in operating assets and liabilities
|
||||||||||
Prepaid
expenses and other current assets
|
117,994
|
120,549
|
264,153
|
|||||||
Accounts
payable and accrued expenses
|
2,054,721
|
(553,710
|
)
|
(2,339,720
|
)
|
|||||
Payable
to related party
|
(34,070
|
)
|
1,043,869
|
1,214,683
|
||||||
Deferred
revenues
|
(183,333
|
)
|
1,362,500
|
—
|
||||||
Accrued
purchase commitment
|
—
|
—
|
(1,645,000
|
)
|
||||||
Other
long-term liabilities
|
28,914
|
378,859
|
33,333
|
|||||||
Net
cash used in operating activities
|
(3,370,844
|
)
|
(2,726,016
|
)
|
(15,694,223
|
)
|
||||
CASH
FLOWS FROM INVESTING ACTIVITIES
|
||||||||||
Proceeds
from release of restricted time deposit upon settlement of purchase
commitment
|
—
|
—
|
3,500,000
|
|||||||
Proceeds
from sales of property and equipment
|
30,280
|
187,708
|
487,691
|
|||||||
Investment
in joint venture
|
—
|
—
|
(26,104
|
)
|
||||||
Purchases
of property and equipment
|
(12,697
|
)
|
(8,729
|
)
|
(1,320
|
)
|
||||
Net
cash provided by investing activities
|
17,583
|
178,979
|
3,960,267
|
Year
Ended December 31,
|
||||||||||
2005
|
2004
|
2003
|
||||||||
CASH
FLOWS FROM FINANCING ACTIVITIES
|
||||||||||
Proceeds
from issuance of common stock
|
800,000
|
2,086,755
|
—
|
|||||||
Proceeds
from issuance of common stock and convertible debentures, net of
issuance
costs and discounts amounting to approximately $3.4
million
|
—
|
—
|
8,711,844
|
|||||||
Proceeds
from issuance of note payable
|
2,500,000
|
—
|
—
|
|||||||
Proceeds
from payment on stock purchase receivable
|
25,000
|
—
|
—
|
|||||||
Proceeds
from release of restricted time deposit upon conversion of convertible
debentures into common stock
|
—
|
—
|
1,800,000
|
|||||||
Proceeds
from release of restricted time deposit upon exchange of convertible
debentures
|
—
|
—
|
2,000,000
|
|||||||
Proceeds
from release of restricted time deposit for repayment of convertible
debentures
|
—
|
—
|
5,200,000
|
|||||||
Repayment
of convertible debentures
|
—
|
(1,110,294
|
)
|
(5,200,000
|
)
|
|||||
Principal
payments on settlements
|
(336,149
|
)
|
(66,387
|
)
|
—
|
|||||
Proceeds
from issuance of notes payable to related party
|
850,000
|
—
|
1,010,000
|
|||||||
Note
payable issuance costs
|
(402,500
|
)
|
—
|
—
|
||||||
Net
cash provided by financing activities
|
3,436,351
|
910,074
|
13,521,844
|
|||||||
Effect
of exchange rate changes on cash and cash equivalents
|
(7,649
|
)
|
7,695
|
2,736
|
||||||
(DECREASE) INCREASE
IN CASH AND CASH EQUIVALENTS
|
75,441
|
(1,629,268
|
)
|
1,790,624
|
||||||
CASH
AND CASH EQUIVALENTS, BEGINNING OF PERIOD
|
272,371
|
1,901,639
|
111,015
|
|||||||
CASH
AND CASH EQUIVALENTS, END OF PERIOD
|
$
|
347,812
|
$
|
272,371
|
$
|
1,901,639
|
||||
SUPPLEMENTAL
DISCLOSURE OF CASH FLOW INFORMATION
|
||||||||||
Cash
paid for
|
||||||||||
Income
taxes
|
$
|
800
|
$
|
800
|
$
|
800
|
||||
Interest
|
410,772
|
111,353
|
21,058
|
|||||||
Common
stock warrants issued in connection with convertible
debentures
|
129,161
|
—
|
745,562
|
|||||||
Conversion
of convertible debentures into common stock
|
837,145
|
6,800,000
|
7,550,000
|
|||||||
Interest
paid in common stock
|
100,758
|
532,644
|
95,339
|
|||||||
Commission
paid in common stock
|
—
|
—
|
29,500
|
|||||||
Common
stock issued to service providers in connection with the March
2003
financing
|
—
|
—
|
484,500
|
2005
|
2004
|
||||||
Prepaid
expenses and other current assets
|
$
|
83,473
|
$
|
83,583
|
|||
Receivable
on sale of equipment
|
—
|
78,009
|
|||||
Related
party receivable
|
—
|
12,875
|
|||||
Retainer
for financing
|
—
|
27,000
|
|||||
Total
Prepaid Expenses and Other Current Assets
|
$
|
83,473
|
$
|
201,467
|
2005
|
2004
|
||||||
Property
and Equipment
|
|||||||
Office
furniture and equipment
|
$
|
158,854
|
$
|
245,274
|
|||
Less:
accumulated depreciation and amortization .
|
(146,863
|
)
|
(236,237
|
)
|
|||
Property
and equipment—net
|
$
|
11,991
|
$
|
9,037
|
|||
Equipment
held for sale
|
$
|
1
|
$
|
1
|
2005
|
2004
|
||||||
Accounts
payable and other accrued expenses
|
$
|
3,137,261
|
$
|
1,333,101
|
|||
Legal
accruals
|
1,283,842
|
1,497,103
|
|||||
Deferred
officer compensation
|
453,544
|
298,194
|
|||||
Accrued
property taxes
|
116,002
|
112,159
|
|||||
Accrued
salaries, wages and benefits
|
281,288
|
258,691
|
|||||
Accrued
legal fees
|
636,733
|
400,278
|
|||||
Total
accounts payable and accrued Expenses
|
$
|
5,908,670
|
$
|
3,899,526
|
2005
|
2004
|
2003
|
|||||||||||||||||
Shares
|
Weighted-Average
Exercise Price
|
Shares
|
Weighted-Average
Exercise Price
|
Shares
|
Weighted-Average
Exercise Price
|
||||||||||||||
Outstanding
at beginning of year
|
1,043,245
|
$
|
12.58
|
384,912
|
$
|
38.24
|
320,924
|
$
|
50.49
|
||||||||||
Granted
|
1,341,520
|
2.00
|
762,498
|
0.78
|
121,699
|
4.87
|
|||||||||||||
Cancelled
|
—
|
—
|
(92,499
|
)
|
15.00
|
(43,748
|
)
|
34.02
|
|||||||||||
Expired
|
(755,340
|
)
|
6.52
|
(11,666
|
)
|
68.95
|
(13,963
|
)
|
42.14
|
||||||||||
Outstanding
at end of year
|
1,629,425
|
$
|
6.68
|
1,043,245
|
$
|
12.58
|
384,912
|
$
|
38.24
|
||||||||||
Options
exercisable at year-end
|
1,051,925
|
$
|
7.41
|
141,162
|
$
|
61.35
|
155,228
|
$
|
61.70
|
Options
Outstanding
|
Options
Exercisable
|
|||||||||||||||
Exercise
Price
|
Number
Outstanding At 12/31/05
|
Weighted-Average
Remaining Contractual Life
|
Weighted-Average
Exercise Price
|
Number
Exercisable At 12/31/05
|
Weighted-Average
Exercise Price
|
|||||||||||
$
0.75
|
100,000
|
8.49
|
$
|
0.75
|
—
|
$
|
—
|
|||||||||
1.85
|
800,000
|
6.53
|
1.85
|
800,000
|
1.85
|
|||||||||||
2.10
|
350,000
|
9.67
|
2.10
|
—
|
—
|
|||||||||||
2.15
|
115,000
|
9.18
|
2.15
|
85,000
|
2.15
|
|||||||||||
2.55
|
4,166
|
3.58
|
2.55
|
4,166
|
2.55
|
|||||||||||
2.85
|
75,000
|
4.56
|
2.85
|
75,000
|
2.85
|
|||||||||||
4.80
|
41,666
|
7.72
|
4.80
|
—
|
—
|
|||||||||||
5.64
|
4,471
|
2.42
|
5.64
|
4,471
|
5.64
|
|||||||||||
15.00
|
8,334
|
0.19
|
15.00
|
8,334
|
15.00
|
|||||||||||
36.00
|
55,834
|
6.53
|
36.00
|
—
|
—
|
|||||||||||
44.04
|
16,666
|
5.36
|
44.04
|
16,666
|
44.04
|
|||||||||||
60.00
|
41,667
|
3.79
|
60.00
|
41,667
|
60.00
|
|||||||||||
91.56
|
10,371
|
0.08
|
91.56
|
10,371
|
91.56
|
|||||||||||
252.00
|
6,250
|
2.38
|
252.00
|
6,250
|
252.00
|
|||||||||||
1,629,425
|
7.26
|
$
|
6.68
|
1,051,925
|
$
|
7.41
|
Year
Ended December 31, 2005
(as
restated)
|
Year
Ended December 31, 2004
|
Year
Ended December 31, 2003
|
||||||||
Net
Loss as reported
|
$
|
6,179,086
|
$
|
7,257,101
|
$
|
18,516,741
|
||||
Deduct:
Stock-based employee compensation expense
|
||||||||||
included
in reported net loss, net of tax
|
—
|
—
|
—
|
|||||||
Add:
Total stock-based employee compensation determined under fair value
based
method for all awards, net of tax
|
3,079,385
|
472,267
|
776,018
|
|||||||
Pro
forma net loss
|
$
|
9,258,471
|
$
|
7,729,368
|
$
|
19,292,759
|
||||
Net
loss per common share
|
||||||||||
As
reported
|
$
|
0.33
|
$
|
0.48
|
$
|
1.40
|
||||
Pro
forma
|
0.49
|
0.51
|
1.45
|
|||||||
Average
risk-free interest rate
|
3.38
|
%
|
4.05
|
%
|
4.53
|
%
|
||||
Average
expected life in years
|
7.17
|
9.5
|
9.5
|
|||||||
Volatility
|
71
|
%
|
80
|
%
|
102
|
%
|
||||
Average
fair value of options granted during the year
|
$
|
1.46
|
$
|
0.64
|
$
|
3.99
|
2005
|
2004
|
||||||
Federal:
|
|||||||
Depreciation
|
$
|
1,273,296
|
$
|
1,375,770
|
|||
Deferred
compensation
|
154,205
|
101,386
|
|||||
Deferred
contributions
|
361,117
|
361,117
|
|||||
Accrued
management fees
|
—
|
272,000
|
|||||
Accrued
vacation
|
44,320
|
87,955
|
|||||
Other
reserves
|
62,333
|
22,258
|
|||||
Net
operating loss carryforward
|
104,184,369
|
99,808,790
|
|||||
Subtotal
|
$
|
106,079,640
|
$
|
102,029,276
|
|||
Valuation
Allowance
|
(106,079,640
|
)
|
(102,029,276
|
||||
Balance
|
$
|
—
|
$
|
—
|
First
|
Second
|
Third
|
Fourth
|
Total
Year
|
||||||||||||
2005
|
||||||||||||||||
Revenues
|
$
|
75,000
|
$
|
58,333
|
$
|
25,000
|
$
|
25,000
|
$
|
183,333
|
||||||
Related
party research and development
|
—
|
—
|
—
|
—
|
—
|
|||||||||||
Other
research and development
|
103,595
|
119,183
|
110,628
|
(132,589
|
)
|
200,817
|
||||||||||
Related
party general & administrative
|
578
|
(4,218
|
)
|
(2,227
|
)
|
5,867
|
—
|
|||||||||
Other
general and administrative
|
1,048,384
|
1,804,774
|
1,810,481
|
1,497,963
|
6,161,602
|
|||||||||||
Net
loss common shareholders
|
$
|
1,077,557
|
$
|
1,861,406
|
$
|
1,893,882
|
$
|
1,346,241
|
$
|
6,179,086
|
||||||
Basic
and diluted loss per common share
|
$
|
.06
|
$
|
.10
|
$
|
.10
|
$
|
.07
|
$
|
.33
|
||||||
Weighted
average common shares outstanding
|
18,250,260
|
18,394,967
|
18,507,916
|
18,853,010
|
18,503,207
|
|||||||||||
2004
|
||||||||||||||||
Revenues
|
$
|
—
|
$
|
25,000
|
$
|
50,000
|
$
|
62,500
|
$
|
137,500
|
||||||
Related
party research and development
|
300,000
|
300,000
|
200,000
|
--
|
800,000
|
|||||||||||
Other
research and development
|
222,538
|
42,913
|
64,121
|
40,591
|
370,163
|
|||||||||||
Other
general and administrative
|
1,173,855
|
1,071,116
|
99,162
|
1,409,769
|
3,753,902
|
|||||||||||
Net
loss common shareholders
|
$
|
2,066,857
|
$
|
2,264,383
|
$
|
1,645,931
|
$
|
1,279,930
|
$
|
7,257,101
|
||||||
Basic
and diluted loss per common share
|
$
|
0.15
|
$
|
0.16
|
$
|
0.12
|
$
|
0.07
|
$
|
0.48
|
||||||
Weighted
average common shares outstanding
|
14,128,966
|
14,128,966
|
14,223,402
|
17,659,043
|
15,046,726
|